KERVALION logo — Surgical Bone Substitute & Regeneration

KERVALION

Surgical Bone Substitute & Regeneration

Founded 2025 France France 3 employees Seed

General Information

Company Name KERVALION
Founded Year 2025
Location France France +1
Employees 3
Funding Stage Seed
Social

Get notified when KERVALION moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About KERVALION

KERVALION, a French startup founded in 2025, is pioneering the development of 3D-printed bone grafts, custom-designed from patient scans. Known for its slogan, "Surgical Bone Substitute & Regeneration", the company initially targets pre-implant dental surgery, offering bespoke grafts that resolve bone deficiencies hindering dental implant placements.

This innovative solution emphasizes personalized manufacturing, enabling grafts to precisely match patient-specific shapes and volumes. Such precision simplifies surgical procedures and reduces the number of interventions needed, offering improved biocompatibility and inspiring substantial bone regeneration. KERVALION is poised to make grafting more accessible and cost-effective for dental professionals, thereby enhancing patient comfort significantly.

The company's most recent spinout investment was made on 01 January 2025, led by University Ventures. KERVALION exemplifies a promising venture in med-tech, offering substantial value in the rapidly evolving landscape of surgical solutions.

Taxonomy: 3D Printing, Bone Grafts, Dental Surgery, Bone Regeneration, Custom Medical Solutions, Biomaterials, Medical Implants, Surgical Innovations, Patient-specific Design, Minimally Invasive Procedures, Biocompatibility, Orthopedic Solutions, Regenerative Medicine

Services & Products

3D Printed Bone Substitutes
Custom Dental Grafts
Bone Regeneration Solutions

Target Customers

Dental Surgeons Dentists Healthcare Providers Oral and Maxillofacial Surgeons

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Spinout •••••• 1
Investor
01 Jan 2025

KERVALION Alternatives & Competitors

View All Alternatives
KERVALION vs

Global Leader in Synthetic & Resorbable Biomaterials

48 employees
Biotechnology, Digital Health
KERVALION vs

L'os humain préservé et régénéré

Private Equity
43 employees
Biotechnology
KERVALION vs

experts in bone regeneration

30 employees
Biotechnology, Manufacturing

FAQ About KERVALION

Surgical Bone Substitute & Regeneration
KERVALION was founded in 2025.
KERVALION is headquartered in France.
KERVALION has approximately 3 employees.
KERVALION has completed 1 funding round. The latest funding stage is Seed.
KERVALION offers: 3D Printed Bone Substitutes, Custom Dental Grafts, Bone Regeneration Solutions.
Top alternatives and competitors to KERVALION include Bonegraft Biomaterials, BIOBank S.A., MBCP® Technology (Advanced Medical Solutions), Cerapedics Inc., TherageniX. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
KERVALION and Bonegraft Biomaterials are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors KERVALION and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy